Qrono immunoengineering technology to address tumor-immunity in cancer patients


Qrono is actively developing patentable therapies that change cancer-immune cell communication.  Their aim is to create cost-effective, low-toxicity treatment options for activating anti-cancer immune cells or for turning “cold” tumors “hot”, outcomes which are rarely realized for patients on current chemo- or immunotherapies.

Contact Us
Email: info@ideafoundry.org
Call: +1.412.682.3067

4551 Forbes Avenue
Pittsburgh, PA 15213

Copyright © 2022 Idea Foundry, Inc. All Rights Reserved.
Photo Credits and Acknowledgments